These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21955390)

  • 21. IgG antiganglioside antibodies in Guillain-Barré syndrome with bulbar palsy.
    Yoshino H; Harukawa H; Asano A
    J Neuroimmunol; 2000 Jun; 105(2):195-201. PubMed ID: 10742563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiology of gangliosides and the role of antiganglioside antibodies in human diseases.
    Cutillo G; Saariaho AH; Meri S
    Cell Mol Immunol; 2020 Apr; 17(4):313-322. PubMed ID: 32152553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.
    Dodd CN; Romio SA; Black S; Vellozzi C; Andrews N; Sturkenboom M; Zuber P; Hua W; Bonhoeffer J; Buttery J; Crawford N; Deceuninck G; de Vries C; De Wals P; Gutierrez-Gimeno MV; Heijbel H; Hughes H; Hur K; Hviid A; Kelman J; Kilpi T; Chuang SK; Macartney K; Rett M; Lopez-Callada VR; Salmon D; Gimenez-Sanchez F; Sanz N; Silverman B; Storsaeter J; Thirugnanam U; van der Maas N; Yih K; Zhang T; Izurieta H;
    Vaccine; 2013 Sep; 31(40):4448-58. PubMed ID: 23770307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.
    Kannan MA; Ch RK; Jabeen SA; Mridula KR; Rao P; Borgohain R
    Neurol India; 2011; 59(5):727-32. PubMed ID: 22019659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Guillain-Barré syndrome after exposure to influenza].
    Hartung HP; Keller-Stanislawski B; Hughes RA; Lehmann HC
    Nervenarzt; 2012 Jun; 83(6):714-30. PubMed ID: 22528062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance for Guillain-Barré syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017-2018 season.
    Perez-Vilar S; Wernecke M; Arya D; Lo AC; Lufkin B; Hu M; Chu S; MaCurdy TE; Kelman J; Forshee RA
    Vaccine; 2019 Jun; 37(29):3856-3865. PubMed ID: 31122853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.
    Kim C; Rhie S; Suh M; Kang DR; Choi YJ; Bae GR; Choi YC; Jun BY; Lee JS
    Vaccine; 2015 Apr; 33(15):1815-23. PubMed ID: 25728315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome.
    van Sorge NM; van der Pol WL; Jansen MD; van den Berg LH
    Autoimmun Rev; 2004 Feb; 3(2):61-8. PubMed ID: 15003189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
    Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
    Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Near real-time surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2010/11 to 2013/14.
    Sandhu SK; Hua W; MaCurdy TE; Franks RL; Avagyan A; Kelman J; Worrall CM; Ball R; Nguyen M
    Vaccine; 2017 May; 35(22):2986-2992. PubMed ID: 28449973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.
    Ghaderi S; Gunnes N; Bakken IJ; Magnus P; Trogstad L; Håberg SE
    Eur J Epidemiol; 2016 Jan; 31(1):67-72. PubMed ID: 26008750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simulation study of the effect of influenza and influenza vaccination on risk of acquiring Guillain-Barré syndrome.
    Hawken S; Kwong JC; Deeks SL; Crowcroft NS; McGeer AJ; Ducharme R; Campitelli MA; Coyle D; Wilson K
    Emerg Infect Dis; 2015 Feb; 21(2):224-31. PubMed ID: 25625590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses.
    Tokars JI; Lewis P; DeStefano F; Wise M; Viray M; Morgan O; Gargiullo P; Vellozzi C
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):546-52. PubMed ID: 22407672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe.
    Dieleman J; Romio S; Johansen K; Weibel D; Bonhoeffer J; Sturkenboom M;
    BMJ; 2011 Jul; 343():d3908. PubMed ID: 21750072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to gangliosides and myelin proteins in Guillain-Barré syndrome.
    Quarles RH; Ilyas AA; Willison HJ
    Ann Neurol; 1990; 27 Suppl():S48-52. PubMed ID: 2194427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series.
    Crawford NW; Cheng A; Andrews N; Charles PG; Clothier HJ; Day B; Day T; Gates P; Macdonell R; Roberts L; Rodriguez-Casero V; Wijeratne T; Kiers L
    Med J Aust; 2012 Nov; 197(10):574-8. PubMed ID: 23163689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.